About Aditum Bio
Aditum is the Latin word for "access," and our mission is to give patients access to medicines that may not otherwise be developed.
Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum Bio brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning and execution for a new model of drug development . We target clinic-ready therapies to help underserved patient populations, rapidly forming companies and staffing them with medical and scientific experts.
Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research, Dr. Mark Fishman, Aditum Bio currently manages a broad portfolio of clinical stage companies.
For more information, please visit www.aditumbio.com.
|
|
|
11-50 employees
View all Aditum Bio employees
|
|
Biotechnology
|
|
1111 Broadway, Suite 1300, Oakland, California 94607, US
|
|
2019
|
Aditum Bio Alternatives
Frequently Asked Questions about Aditum Bio
The decision makers in Aditum Bio are Adam Fowler, Chris Resburg, Chris Resburg, etc. Click to Find Aditum Bio decision makers emails.
Aditum Bio Staff Directory
Search Aditum Bio Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
